Annual Long Term Liabilities:
$60.09M-$2.85M(-4.53%)Summary
- As of today, ACAD annual total long term liabilities is $60.09 million, with the most recent change of -$2.85 million (-4.53%) on December 31, 2024.
- During the last 3 years, ACAD annual long term liabilities has fallen by -$3.07 million (-4.86%).
- ACAD annual long term liabilities is now -21.07% below its all-time high of $76.14 million, reached on December 31, 2003.
Performance
ACAD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$73.15M+$8.55M(+13.24%)Summary
- As of today, ACAD quarterly total long term liabilities is $73.15 million, with the most recent change of +$8.55 million (+13.24%) on June 30, 2025.
- Over the past year, ACAD quarterly long term liabilities has increased by +$13.60 million (+22.84%).
- ACAD quarterly long term liabilities is now -3.93% below its all-time high of $76.14 million, reached on December 31, 2003.
Performance
ACAD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ACAD Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -4.5% | +22.8% |
| 3Y3 Years | -4.9% | +21.4% |
| 5Y5 Years | +551.6% | +616.2% |
ACAD Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -4.9% | at low | at high | +31.2% |
| 5Y | 5-Year | -4.9% | +551.6% | at high | +49.5% |
| All-Time | All-Time | -21.1% | >+9999.0% | -3.9% | >+9999.0% |
ACAD Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $73.15M(+13.2%) |
| Mar 2025 | - | $64.60M(+7.5%) |
| Dec 2024 | $60.09M(-4.5%) | $60.09M(+7.8%) |
| Sep 2024 | - | $55.74M(-6.4%) |
| Jun 2024 | - | $59.55M(-1.5%) |
| Mar 2024 | - | $60.46M(-3.9%) |
| Dec 2023 | $62.95M(+1.9%) | $62.95M(+3.6%) |
| Sep 2023 | - | $60.76M(+2.9%) |
| Jun 2023 | - | $59.03M(+4.0%) |
| Mar 2023 | - | $56.75M(-8.1%) |
| Dec 2022 | $61.77M(-2.2%) | $61.77M(+2.5%) |
| Sep 2022 | - | $60.23M(-0.0%) |
| Jun 2022 | - | $60.24M(+0.6%) |
| Mar 2022 | - | $59.85M(-5.2%) |
| Dec 2021 | $63.16M(+27.2%) | $63.16M(+1.1%) |
| Sep 2021 | - | $62.50M(-2.7%) |
| Jun 2021 | - | $64.26M(+0.1%) |
| Mar 2021 | - | $64.19M(+29.3%) |
| Dec 2020 | $49.64M(+438.3%) | $49.64M(+1.4%) |
| Sep 2020 | - | $48.94M(+379.2%) |
| Jun 2020 | - | $10.21M(+9.5%) |
| Mar 2020 | - | $9.33M(+1.1%) |
| Dec 2019 | $9.22M(+491.9%) | $9.22M(+7.8%) |
| Sep 2019 | - | $8.55M(+4.9%) |
| Jun 2019 | - | $8.15M(+5.0%) |
| Mar 2019 | - | $7.77M(+398.5%) |
| Dec 2018 | $1.56M(+715.7%) | $1.56M(+28.9%) |
| Sep 2018 | - | $1.21M(+17.8%) |
| Jun 2018 | - | $1.03M(+31.2%) |
| Mar 2018 | - | $782.00K(+309.4%) |
| Dec 2017 | $191.00K(+21.7%) | $191.00K(-22.0%) |
| Sep 2017 | - | $245.00K(-6.5%) |
| Jun 2017 | - | $262.00K(+17.0%) |
| Mar 2017 | - | $224.00K(+42.7%) |
| Dec 2016 | $157.00K(-32.3%) | $157.00K(-11.3%) |
| Sep 2016 | - | $177.00K(-10.2%) |
| Jun 2016 | - | $197.00K(-9.2%) |
| Mar 2016 | - | $217.00K(-6.5%) |
| Dec 2015 | $232.00K(+71.9%) | $232.00K(-2.9%) |
| Sep 2015 | - | $239.00K(-29.7%) |
| Jun 2015 | - | $340.00K(+56.0%) |
| Mar 2015 | - | $218.00K(+61.5%) |
| Dec 2014 | $135.00K | $135.00K(+542.9%) |
| Sep 2014 | - | $21.00K(+16.7%) |
| Jun 2014 | - | $18.00K(+38.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $13.00K(+62.5%) |
| Dec 2013 | $8000.00(-100.0%) | $8000.00(-99.9%) |
| Sep 2013 | - | $10.66M(-39.6%) |
| Jun 2013 | - | $17.66M(0.0%) |
| Mar 2013 | - | $17.66M(0.0%) |
| Dec 2012 | $17.66M(+582.6%) | $17.66M(>+9900.0%) |
| Sep 2012 | - | $0.00(-100.0%) |
| Jun 2012 | - | $2.41M(-3.8%) |
| Mar 2012 | - | $2.50M(-3.3%) |
| Dec 2011 | $2.59M(-5.8%) | $2.59M(+4.8%) |
| Sep 2011 | - | $2.47M(-2.8%) |
| Jun 2011 | - | $2.54M(-3.8%) |
| Mar 2011 | - | $2.64M(-3.9%) |
| Dec 2010 | $2.75M(-88.0%) | $2.75M(-87.9%) |
| Sep 2010 | - | $22.76M(-1.2%) |
| Jun 2010 | - | $23.03M(+1.8%) |
| Mar 2010 | - | $22.63M(-1.0%) |
| Dec 2009 | $22.86M(+3505.5%) | $22.86M(-5.8%) |
| Sep 2009 | - | $24.26M(+6.8%) |
| Jun 2009 | - | $22.71M(+4037.3%) |
| Mar 2009 | - | $549.00K(-13.4%) |
| Dec 2008 | $634.00K(-53.5%) | $634.00K(-16.5%) |
| Sep 2008 | - | $759.00K(-23.1%) |
| Jun 2008 | - | $987.00K(-16.8%) |
| Mar 2008 | - | $1.19M(-13.0%) |
| Dec 2007 | $1.36M(-26.4%) | $1.36M(-6.5%) |
| Sep 2007 | - | $1.46M(-10.3%) |
| Jun 2007 | - | $1.63M(-3.3%) |
| Mar 2007 | - | $1.68M(-9.2%) |
| Dec 2006 | $1.85M(+29.1%) | $1.85M(+6.0%) |
| Sep 2006 | - | $1.75M(+1.7%) |
| Jun 2006 | - | $1.72M(-10.4%) |
| Mar 2006 | - | $1.92M(+33.6%) |
| Dec 2005 | $1.43M(+37.4%) | $1.43M(+3.6%) |
| Sep 2005 | - | $1.38M(-1.3%) |
| Jun 2005 | - | $1.40M(-24.6%) |
| Mar 2005 | - | $1.86M(+78.3%) |
| Dec 2004 | $1.04M(-98.6%) | $1.04M(+1.7%) |
| Sep 2004 | - | $1.03M(+8.5%) |
| Jun 2004 | - | $946.30K(-98.7%) |
| Mar 2004 | - | $75.39M(-1.0%) |
| Dec 2003 | $76.14M(+52.4%) | $76.14M |
| Dec 2002 | $49.96M(+3676.3%) | - |
| Dec 2001 | $1.32M(-77.1%) | - |
| Dec 2000 | $5.79M | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual total long term liabilities?
- What is the all-time high annual long term liabilities for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual long term liabilities year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly long term liabilities year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual total long term liabilities?
The current annual long term liabilities of ACAD is $60.09M
What is the all-time high annual long term liabilities for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual total long term liabilities is $76.14M
What is ACADIA Pharmaceuticals Inc. annual long term liabilities year-on-year change?
Over the past year, ACAD annual total long term liabilities has changed by -$2.85M (-4.53%)
What is ACADIA Pharmaceuticals Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of ACAD is $73.15M
What is the all-time high quarterly long term liabilities for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly total long term liabilities is $76.14M
What is ACADIA Pharmaceuticals Inc. quarterly long term liabilities year-on-year change?
Over the past year, ACAD quarterly total long term liabilities has changed by +$13.60M (+22.84%)